Cargando…
Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels
OBJECTIVE: The aim of this study was to confirm determinative factors for plasma Aβ and its association with cognitive function. METHODS: Fasting plasma Aβ40 and Aβ42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma Aβ and hea...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186936/ https://www.ncbi.nlm.nih.gov/pubmed/30349853 http://dx.doi.org/10.1002/acn3.635 |
_version_ | 1783362937829720064 |
---|---|
author | Nakamura, Takumi Kawarabayashi, Takeshi Seino, Yusuke Hirohata, Mie Nakahata, Naoko Narita, Sakiko Itoh, Ken Nakaji, Shigeyuki Shoji, Mikio |
author_facet | Nakamura, Takumi Kawarabayashi, Takeshi Seino, Yusuke Hirohata, Mie Nakahata, Naoko Narita, Sakiko Itoh, Ken Nakaji, Shigeyuki Shoji, Mikio |
author_sort | Nakamura, Takumi |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to confirm determinative factors for plasma Aβ and its association with cognitive function. METHODS: Fasting plasma Aβ40 and Aβ42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma Aβ and health‐related items, including physical characteristics, cognitive function tests, blood chemistry, and APOE‐ε4 genotype were analyzed. RESULTS: The plasma levels of Aβ40 and Aβ42, and Aβ40/42 ratio were found to significantly increase with aging. The age‐dependent increase in Aβ42 level was significantly suppressed by APOE‐ε4. Renal function was an associated factor for the plasma Aβ40 level. The plasma Aβ42 level and Aβ40/42 ratio correlated with cognitive function. INTERPRETATION: Age and APOE‐ε4 are major determinative factors of plasma levels of Aβ42 and the Aβ40/42 ratio. These factors are critical adjustment factors for the usage of plasma Aβ as a biomarker of central nervous system amyloidosis. |
format | Online Article Text |
id | pubmed-6186936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61869362018-10-22 Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels Nakamura, Takumi Kawarabayashi, Takeshi Seino, Yusuke Hirohata, Mie Nakahata, Naoko Narita, Sakiko Itoh, Ken Nakaji, Shigeyuki Shoji, Mikio Ann Clin Transl Neurol Research Articles OBJECTIVE: The aim of this study was to confirm determinative factors for plasma Aβ and its association with cognitive function. METHODS: Fasting plasma Aβ40 and Aβ42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma Aβ and health‐related items, including physical characteristics, cognitive function tests, blood chemistry, and APOE‐ε4 genotype were analyzed. RESULTS: The plasma levels of Aβ40 and Aβ42, and Aβ40/42 ratio were found to significantly increase with aging. The age‐dependent increase in Aβ42 level was significantly suppressed by APOE‐ε4. Renal function was an associated factor for the plasma Aβ40 level. The plasma Aβ42 level and Aβ40/42 ratio correlated with cognitive function. INTERPRETATION: Age and APOE‐ε4 are major determinative factors of plasma levels of Aβ42 and the Aβ40/42 ratio. These factors are critical adjustment factors for the usage of plasma Aβ as a biomarker of central nervous system amyloidosis. John Wiley and Sons Inc. 2018-09-07 /pmc/articles/PMC6186936/ /pubmed/30349853 http://dx.doi.org/10.1002/acn3.635 Text en © 2018 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Nakamura, Takumi Kawarabayashi, Takeshi Seino, Yusuke Hirohata, Mie Nakahata, Naoko Narita, Sakiko Itoh, Ken Nakaji, Shigeyuki Shoji, Mikio Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels |
title | Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels |
title_full | Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels |
title_fullStr | Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels |
title_full_unstemmed | Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels |
title_short | Aging and APOE‐ε4 are determinative factors of plasma Aβ42 levels |
title_sort | aging and apoe‐ε4 are determinative factors of plasma aβ42 levels |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186936/ https://www.ncbi.nlm.nih.gov/pubmed/30349853 http://dx.doi.org/10.1002/acn3.635 |
work_keys_str_mv | AT nakamuratakumi agingandapoee4aredeterminativefactorsofplasmaab42levels AT kawarabayashitakeshi agingandapoee4aredeterminativefactorsofplasmaab42levels AT seinoyusuke agingandapoee4aredeterminativefactorsofplasmaab42levels AT hirohatamie agingandapoee4aredeterminativefactorsofplasmaab42levels AT nakahatanaoko agingandapoee4aredeterminativefactorsofplasmaab42levels AT naritasakiko agingandapoee4aredeterminativefactorsofplasmaab42levels AT itohken agingandapoee4aredeterminativefactorsofplasmaab42levels AT nakajishigeyuki agingandapoee4aredeterminativefactorsofplasmaab42levels AT shojimikio agingandapoee4aredeterminativefactorsofplasmaab42levels |